A case of carbidopa/levodopa associated colitis mimicking inflammatory bowel disease
Carbidopa/levodopa is widely used in the management of Parkinson's disease. We report a 77-year-old male with Parkinson's disease who developed severe, protracted pancolitis and ileitis after 5-months of treatment with carbidopa/levodopa. The clinical presentation and endoscopic findings i...
Saved in:
Main Authors: | Michael J. Steel (Author), James Conner (Author), Sandra Nelles (Author), Richard Kirsch (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Xanthonychia Due to Staining From Carbidopa-Levodopa
by: Jonathan Kyle Hwang, et al.
Published: (2023) -
Istradefylline: A novel agent in the treatment of "off" episodes associated with levodopa/carbidopa use in Parkinson disease
by: Lauren Cummins, et al.
Published: (2022) -
Pharmaceutical and pharmacokinetic evaluation of a newly formulated multiparticulate matrix of levodopa and carbidopa
by: Emelia Priscilla Imbeah, et al.
Published: (2022) -
Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
by: Yi ZM, et al.
Published: (2018) -
Strongyloides Colitis as a Harmful Mimicker of Inflammatory Bowel Disease
by: Julio Poveda, et al.
Published: (2017)